Second Dose of Palonosetron Reduces CINV in Pediatric Cancer Patients
An additional dose of palonosetron can help prevent chemotherapy-induced nausea and vomiting (CINV) in children with cancer who are receiving multiple-day moderately or highly emetogenic chemotherapy, a randomized study suggests.